{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:12:53Z","timestamp":1761520373783,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.clcc.2023.05.004","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T20:56:11Z","timestamp":1684788971000},"page":"318-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Revisiting the Radical Radiotherapy-Radiochemotherapy Results in Anal Canal Cancers: (TROD Gastrointestinal Group Study 02-005)"],"prefix":"10.1016","volume":"22","author":[{"given":"Sule Karabulut","family":"GUL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Tepetam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferah","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilhami","family":"Er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didem Colpan","family":"Oksuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murtaza","family":"Parvizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Sevgi","family":"Ozden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zumre Arican","family":"Alicikus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sezin Yuce","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3651-4129","authenticated-orcid":false,"given":"Omar","family":"Alomari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilknur Bilkay","family":"Gorken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clcc.2023.05.004_bib0001","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.clcc.2023.05.004_bib0002","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1634\/theoncologist.12-5-524","article-title":"Anal cancer: an overview","volume":"12","author":"Uronis","year":"2007","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.clcc.2023.05.004_bib0003","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/ijc.24215","article-title":"Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions","volume":"124","author":"Hoots","year":"2009","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.clcc.2023.05.004_bib0004","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clcc.2023.05.004_bib0005","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/PGP.0b013e3181aaba0d","article-title":"Human papillomavirus types in invasive cervical cancer specimens from Turkey","volume":"28","author":"Usub\u00fct\u00fcn","year":"2009","journal-title":"Int J Gynecol Pathol"},{"issue":"9034","key":"10.1016\/j.clcc.2023.05.004_bib0006","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin","volume":"348","author":"Party","year":"1996","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.clcc.2023.05.004_bib0007","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/1097-0142(19910415)67:8<2038::AID-CNCR2820670805>3.0.CO;2-R","article-title":"Treatment of squamous cell carcinoma of the anal canal","volume":"67","author":"Miller","year":"1991","journal-title":"Cancer"},{"issue":"suppl 18","key":"10.1016\/j.clcc.2023.05.004_bib0008","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1200\/jco.2006.24.18_suppl.4009","article-title":"Intergroup RTOG 98\u201311: a phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal","volume":"24","author":"Ajani","year":"2006","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.clcc.2023.05.004_bib0009","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199711063371904","article-title":"Sexually transmitted infection as a cause of anal cancer","volume":"337","author":"Frisch","year":"1997","journal-title":"N Engl J Med"},{"issue":"9034","key":"10.1016\/j.clcc.2023.05.004_bib0010","first-page":"4009","article-title":"AJCC cancer staging manual","volume":"24","author":"Siegel","year":"1996","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2023.05.004_bib0011","first-page":"139","article-title":"Anal cancer: current standards in care and recent changes in practice","volume":"65","author":"Shridhar","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.clcc.2023.05.004_bib0012","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.radonc.2014.04.013","article-title":"Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"111","author":"Glynne-Jones","year":"2014","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.clcc.2023.05.004_bib0013","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.2012.45.2524","article-title":"Changing patterns of anal canal carcinoma in the United States","volume":"31","author":"Nelson","year":"2013","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2023.05.004_bib0014","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.ijrobp.2011.12.062","article-title":"Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort","volume":"83","author":"Bentzen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clcc.2023.05.004_bib0015","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00330-017-5026-2","article-title":"Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting","volume":"28","author":"Beets-Tan","year":"2018","journal-title":"Eur Radiol"},{"issue":"11","key":"10.1016\/j.clcc.2023.05.004_bib0016","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1245\/s10434-015-4391-9","article-title":"The role of FDG-PET in the initial staging and response assessment of anal cancer: a systematic review and meta-analysis","volume":"22","author":"Jones","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.05.004_bib0017","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10350-004-6108-1","article-title":"Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal: potential implications of a new ultrasound staging system","volume":"45","author":"Tarantino","year":"2002","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.clcc.2023.05.004_bib0018","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00024382-199910000-00019","article-title":"Principles and practice of surgery for the colon, rectum, and anus","volume":"12","author":"Gordon","year":"1999","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.clcc.2023.05.004_bib0019","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF02554359","article-title":"Long-term prognosis after radical treatment for squamous-cell carcinoma of the anal canal and anal margin","volume":"31","author":"Jensen","year":"1988","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"10.1016\/j.clcc.2023.05.004_bib0020","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1686::AID-CNCR7>3.0.CO;2-7","article-title":"Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes","volume":"85","author":"Klas","year":"1999","journal-title":"Cancer"},{"issue":"35","key":"10.1016\/j.clcc.2023.05.004_bib0021","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.clcc.2023.05.004_bib0022","first-page":"4509","article-title":"Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix","volume":"56","author":"Hockel","year":"1996","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.clcc.2023.05.004_bib0023","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0360-3016(03)00123-8","article-title":"Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis","volume":"56","author":"Dunst","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clcc.2023.05.004_bib0024","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2011.03.004","article-title":"Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis","volume":"100","author":"Overgaard","year":"2011","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clcc.2023.05.004_bib0025","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: a preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"10.1016\/j.clcc.2023.05.004_bib0026","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR anal cancer trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.clcc.2023.05.004_bib0027","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.clcc.2023.05.004_bib0028","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archsurg.136.8.886","article-title":"The evolving treatment of anal cancer: how are we doing?","volume":"136","author":"Whiteford","year":"2001","journal-title":"Arch Surg"},{"issue":"16","key":"10.1016\/j.clcc.2023.05.004_bib0029","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.clcc.2023.05.004_bib0030","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00a0\u00d7\u00a02 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clcc.2023.05.004_bib0031","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.radonc.2007.12.004","article-title":"Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03)","volume":"87","author":"Tournier-Rangeard","year":"2008","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.clcc.2023.05.004_bib0032","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.ijrobp.2004.07.687","article-title":"Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness","volume":"61","author":"Ferrigno","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.clcc.2023.05.004_bib0033","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3748\/wjg.v13.i6.895","article-title":"Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal","volume":"13","author":"Huang","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.clcc.2023.05.004_bib0034","first-page":"205","article-title":"Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08","volume":"2","author":"John","year":"1996","journal-title":"Cancer J Sci Am"},{"issue":"2","key":"10.1016\/j.clcc.2023.05.004_bib0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2004.09.060","article-title":"Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy","volume":"62","author":"Ortholan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clcc.2023.05.004_bib0036","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clcc.2023.05.004_bib0037","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clcc.2023.05.004_bib0038","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ijrobp.2008.02.053","article-title":"Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis","volume":"72","author":"McDonald","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clcc.2023.05.004_bib0039","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2012.06.006","article-title":"Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin","volume":"104","author":"Sebag-Montefiore","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2023.05.004_bib0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-717X-5-36","article-title":"Chemo-radiation with or without mandatory split in anal carcinoma: experiences of two institutions and review of the literature","volume":"5","author":"Oehler","year":"2010","journal-title":"Radiat Oncol"},{"issue":"11","key":"10.1016\/j.clcc.2023.05.004_bib0041","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/0284186X.2018.1503713","article-title":"Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review","volume":"57","author":"Bin","year":"2018","journal-title":"Acta Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002823000579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002823000579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:08:48Z","timestamp":1761520128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002823000579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1533002823000579"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2023.05.004","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting the Radical Radiotherapy-Radiochemotherapy Results in Anal Canal Cancers: (TROD Gastrointestinal Group Study 02-005)","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2023.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}